3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Flupenthixol: new trials by email Literature Review of Flupenthixol trials Research Report on Flupenthixol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients Flupentixol, Multi-acting receptor-targeted antipsychotics (MARTAs) - Schizophrenia; Psychosis, Metabolic Syndrome | Phase 4 | Completed | Taichung Veterans General Hospital | 30 | 2019-12-19 | 2021-05-24 |
| Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Omeprazole, Flupentixol-Melitracen(psychological and GI) + Omeprazole, Flupentixol-Melitracen(psychological) + Omeprazole - Dyspepsia, Compliance | Phase 4 | Completed | RenJi Hospital | 262 | 2013-05-01 | 2015-02-23 |
| Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia Olanzapine, Flupentixol, Quetiapine - Schizophrenia | Phase 4 | Completed | University of Bremen | 149 | 2010-02-01 | 2015-06-22 |
Schizophrenia (2) · Central Nervous System Diseases (1) · Depression (1) · Dyspepsia (1) · Metabolic Syndrome (1) · Patient Compliance (1) · Psychotic Disorders (1)
RenJi Hospital (1) · Taichung Veterans General Hospital (1) · University of Bremen (1)
China (1) · Germany (1) · Taiwan (1)
Chia-Jui Tsai, M.D. (1) · Shengliang Chen (1)
PMID 25914475, PMID 27016729, PMID 27265548, PMID 30981585, PMID 38958149
2009 (1)